Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $3 | $19 | $22 | $16 |
| % Growth | -85.7% | -13.8% | 41.1% | – |
| Cost of Goods Sold | $2 | $16 | $18 | $14 |
| Gross Profit | $0 | $3 | $5 | $2 |
| % Margin | 16.1% | 15.8% | 20.5% | 13% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | -$0 | $1 | -$1 |
| SG&A Expenses | $0 | -$1 | $2 | -$3 |
| Sales & Mktg Exp. | $0 | -$0 | $2 | -$2 |
| Other Operating Expenses | $0 | $3 | $0 | $5 |
| Operating Expenses | $0 | $2 | $2 | $2 |
| Operating Income | $0 | $1 | $2 | -$0 |
| % Margin | 5.2% | 4.1% | 9.9% | -2.5% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $0 | $1 | $2 | -$0 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | $0 | $1 | $2 | -$0 |
| % Margin | 4% | 3.6% | 8.1% | -2% |
| EPS | 0.069 | 0.43 | 1.12 | -0.2 |
| % Growth | -84.1% | -61.6% | 660% | – |
| EPS Diluted | 0.069 | 0.43 | 1.12 | -0.2 |
| Weighted Avg Shares Out | 2 | 2 | 2 | 2 |
| Weighted Avg Shares Out Dil | 2 | 2 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $1 | $2 | -$0 |
| % Margin | 6% | 5% | 10.4% | -1.9% |